IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10238736 B1

PDFFull Text
Date of Patent:
Mar. 26, 2019

Filed:

Apr. 26, 2017

Adjuvant compositions

Applicant:

Zoetis Services Llc, Parsippany, NJ (US);

Inventors:

Paul Joseph Dominowski, Kalamazoo, MI (US);

Ramasamy Mannar Mannan, Woburn, MA (US);

Richard Lee Krebs, Ashland, NE (US);

James Richard Thompson, Portage, MI (US);

Tedd Alan Childers, Portage, MI (US);

Mary Kathryn Olsen, Kalamazoo, MI (US);

Robert John Yancey, Jr., Portage, MI (US);

Risini Dhammika Weeratna, Ottawa, CA;

Shucheng Zhang, Shanghai, CN;

Cedo Martin Bagi, Branford, CT (US);

Assignee:

Zoetis Services LLC, Parsippany, NJ (US);

Attorney:

Vyacheslav Vasilyev

Primary Examiner:

Janet L Andres

Assistant Examiner:

Stuart W Snyder

Int. Cl.
CPC ...
A61K 39/39 (2006.01); A61K 39/00 (2006.01); A61K 39/012 (2006.01); A61K 39/02 (2006.01); A61K 39/108 (2006.01); A61K 39/12 (2006.01); A61K 39/145 (2006.01); A61K 39/15 (2006.01); A61K 39/21 (2006.01); A61K 39/215 (2006.01); A61K 39/002 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); A61K 39/002 (2013.01); A61K 39/0011 (2013.01); A61K 39/012 (2013.01); A61K 39/0208 (2013.01); A61K 39/0241 (2013.01); A61K 39/0258 (2013.01); A61K 39/12 (2013.01); A61K 39/145 (2013.01); A61K 39/15 (2013.01); A61K 39/21 (2013.01); A61K 39/215 (2013.01); A61K 2039/521 (2013.01); A61K 2039/5252 (2013.01); A61K 2039/5254 (2013.01); A61K 2039/54 (2013.01); A61K 2039/55 (2013.01); A61K 2039/552 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/55511 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/55561 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/55572 (2013.01); A61K 2039/55577 (2013.01); C12N 2720/12334 (2013.01); C12N 2720/12351 (2013.01); C12N 2740/13034 (2013.01); C12N 2740/13051 (2013.01); C12N 2760/16134 (2013.01); C12N 2760/16151 (2013.01); C12N 2770/20034 (2013.01); C12N 2770/20051 (2013.01); C12N 2770/24334 (2013.01); C12N 2770/24351 (2013.01); Y02A 50/474 (2018.01);
Abstract

This invention relates to adjuvant formulations comprising various combinations of triterpenoids, sterols, immunomodulators, polymers, and Th2 stimulators; methods for making the adjuvant compositions; and the use of the adjuvant formulations in immunogenic and vaccine compositions with different antigens. This invention further relates to the use of the formulations in the treatment of animals.

Find Patent Forward Citations

Loading…